We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04305054
Brief Title: Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

First Submitted : March 9, 2020
First Submitted that Met QC Criteria : March 9, 2020
First Posted : March 12, 2020

Last Update Submitted that Met QC Criteria : March 15, 2023
Last Update Posted : March 16, 2023